Información de Mallinckrodt (MNK)

Mallinckrodt (MNK)
Mallinckrodt (MNK)

Noticias sobre Mallinckrodt (MNK)

Re: Farmas USA

Amarin (NASDAQ:AMRN) Q4 results ($M): Revenues: 16.5 (+63.5%); Operating Expenses: 30.8 (-20.8%); Net Loss: (19.7) (-27.6%); Loss Per Share: (0.11) (+59.3%); Quick Assets: 119.5 (-37.6%). Vascepa revenue of $16.5M represented a sequential increase of...

Re: Farmas USA

report Q4 ARNA Arena Pharmaceuticals (NASDAQ:ARNA): Q4 EPS of -$0.15 misses...

Re: Farmas USA

Arena Pharmaceuticals beats by $0.07, misses on revenue • 6:56 AM Mohit...